Using random forest and biomarkers for differentiating COVID-19 and Mycoplasma pneumoniae infections.

MLA

Zhou, Xun, et al. “Using Random Forest and Biomarkers for Differentiating COVID-19 and Mycoplasma Pneumoniae Infections.” Scientific Reports, vol. 14, no. 1, Sept. 2024, p. 22673. EBSCOhost, https://doi.org/10.1038/s41598-024-74057-5.

APA

Zhou, X., Zhang, J., Deng, X.-M., Fu, F.-M., Wang, J.-M., Zhang, Z.-Y., Zhang, X.-Q., Luo, Y.-X., & Zhang, S.-Y. (2024). Using random forest and biomarkers for differentiating COVID-19 and Mycoplasma pneumoniae infections. Scientific Reports, 14(1), 22673. https://doi.org/10.1038/s41598-024-74057-5

Chicago

Zhou, Xun, Jie Zhang, Xiu-Mei Deng, Fang-Mei Fu, Juan-Min Wang, Zhong-Yuan Zhang, Xian-Qiang Zhang, Yue-Xing Luo, and Shi-Yan Zhang. 2024. “Using Random Forest and Biomarkers for Differentiating COVID-19 and Mycoplasma Pneumoniae Infections.” Scientific Reports 14 (1): 22673. doi:10.1038/s41598-024-74057-5.